dexmedetomidine has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Ghaffar, MA; Hammouda, MA; Saleh, AAG; Shawki, A; Sultan, A | 1 |
| Ikegaki, J; Komasawa, N | 1 |
2 other study(ies) available for dexmedetomidine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Value of Adding Dexmedetomidine in Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis for Treatment of Pancreatic Cancer-Associated Pain.
Topics: Aged; Bupivacaine; Cancer Pain; Case-Control Studies; Celiac Plexus; Dexmedetomidine; Endosonography; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nerve Block; Pain Measurement; Pancreas; Pancreatic Neoplasms; Prospective Studies; Treatment Outcome; Ultrasonography, Interventional | 2021 |
[A case of dexmedetomidine administration for slight end-stage sedation in a patient with sudden continuous bleeding].
Topics: Conscious Sedation; Dexmedetomidine; Hemorrhage; Humans; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms | 2014 |